Company / Operating Margin
iBio, Inc. Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-7392.9%
FY2025
5-year range
-7392.9% / -854.9%
FY2021-FY2025
Trend
-
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin changed -369% YoY in FY2025, a notable deviation from the 8-year average annual change of -100%.
Based on SEC 10-K filings.
-7392.9% in FY2025 with a 5-year CAGR of -6610.5%.
Declined from -1312.1% to -7392.9% over the past 3 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -6080.7pp
- 5-Year Change
- -6610.5pp
- 10-Year Change
- -
Key checks
Key Insights
- Peak operating margin was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score -1.36 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -7392.9% | - |
| FY2024 | - | - |
| FY2023 | -1576.3% | -20.1% |
| FY2022 | -1312.1% | -53.5% |
| FY2021 | -854.9% | -9.3% |
| FY2020 | -782.4% | +75.6% |
| FY2019 | -3204.3% | +11.6% |
| FY2018 | -3622.8% | -247.2% |
| FY2017 | -1043.6% | -189.8% |
| FY2016 | -360.1% | +80.8% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026